COPD Market Analysis and Reports | Japan Conference Series

Market Analysis - COPD 2018

COPD 2018 Conference

The global COPD market is estimated to currently be worth $11.3 billion, and is forecast to reach a value of $15.6 billion by 2019. The drugs driving this growth include once-daily LABA/LAMA fixed-dose combinations such as QVA-149, umeclidinium bromide/vilanterol and olodaterol/tiotropium.

The opportunity in the U.S. and China asthma and COPD drugs market is slated to rise from a valuation of US$13.0 bn in 2015 to be worth US$18.7 bn by 2024. If these values hold true, the market is likely to expand at a modest CAGR of 4.1% therein.

 

North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.

The current asthma and COPD market is primarily driven by increasing patient population. It is also growing due to factors such as price erosion and expiry of patents of leading drug brands in the market. However, it is estimated that in the next five years, the global asthma and COPD drug market is expected to grow slowly and steadfast. The COPD segment was projected to be worth USD 10,593.2 million and is expected to reach USD 12,619.8 million in 2017.

In Europe, LABA / ICS combinations and LTA (Montelukast) drugs are more popular for asthma and COPD treatment.

TOP FACTORS IMPACTING GLOBAL COPD AND ASTHMA DEVICES MARKET

Top few companies in this global market:

AstraZeneca

GlaxoSmithKline

F. Hoffmann-La Roche

Novartis and Merck

Abbott

Amgen

Actavis

Boehringer Ingelheim

Cipla

Glenmark

Pfizer

Ranbaxy

Sunovion

Vectura

Global COPD & Asthma Devices Market, By Product

Inhalers

Nebulizers

Inhalers accounted for the major market and is expected to continue its dominance till 2020

Global COPD & Asthma Devices Market, By Geography

North America

Europe

Asia-Pacific

LAMEA

LAMEA region would exhibit the highest CAGR of 4.9% during 2017-2020

Bibiliography

https://industrytoday.co.uk/market-research-industry-today/global-asthma-and-copd-drug-market-market-research-size-growth-trend-analysis-

http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=145

http://www.grandviewresearch.com/industry-analysis/asthma-and-copd-market

https://www.alliedmarketresearch.com/COPD-asthma-devices-market

http://www.gbiresearch.com/report-store/market-reports/therapy-analysis/chronic-obstructive-pulmonary-disease-(copd)-market-to-2019-highly-priced-new-combination-products-forecast-to-capture-signif